The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

Incyte Corp

Nasdaq: INCY
Last

(U.S.) $75.01

Today's change+1.87 +2.56%
Updated November 26 4:00 PM EST. Delayed by at least 15 minutes.
 

Incyte Corp

Nasdaq: INCY
Last

(U.S.) $75.01

Today's change+1.87 +2.56%
Updated November 26 4:00 PM EST. Delayed by at least 15 minutes.

Incyte Corp up sharply

Incyte Corp closed up sharply Wednesday, rallying (U.S.)$1.87 or 2.56% to (U.S.)$75.01. Over the last five days, shares have gained 5.20% and are currently 1.15% off of the 52-week high. Shares have outperformed the S&P 500 by 43.15% during the last year.

Key company metrics

  • Open(U.S.) $73.10
  • Previous close(U.S.) $73.14
  • High(U.S.) $75.01
  • Low(U.S.) $72.82
  • Bid / Ask-- / --
  • YTD % change+48.15%
  • Volume804,565
  • Average volume (10-day)1,829,016
  • Average volume (1-month)1,690,599
  • Average volume (3-month)1,241,508
  • 52-week range(U.S.) $40.30 to (U.S.) $75.88
  • Beta1.07
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$0.37
Updated November 26 4:00 PM EST. Delayed by at least 15 minutes.
S&P TSX0.23%Sector:HealthcareIndustry:Biotechnology
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2014Q2/2014Q1/2014Q4/2013
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014Dec 31, 201312/31/2013
Revenue1981009097
Total other revenue--------
Total revenue1981009097
Gross profit198999097
Total cost of revenue0000
Total operating expense128126113113
Selling / general / administrative39413738
Research & development89857675
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income70-26-23-16
Interest income (expense), net non-operating-11-11-11-9
Gain (loss) on sale of assets--------
Other--------
Income before tax59-37-34-43
Income after tax59-37-34-43
Income tax, total0000
Net income59-37-34-43
Total adjustments to net income--------
Net income before extra. items59-37-34-43
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items59-37-34-43
Inc. avail. to common incl. extra. items59-37-34-43
Diluted net income59-37-34-43
Dilution adjustment----00
Diluted weighted average shares189168165162
Diluted EPS excluding extraordinary itemsvalue per share0.31-0.22-0.21-0.26
Dividends per sharevalue per share0.000.000.00--
Diluted normalized EPSvalue per share0.31-0.22-0.21-0.26